The TII-Diabetes drug Acarbose inhibits reprogramming of differentiated cells into induced pluripotent stem cells through its target genes, 13/March/2014, 22.28

Molecular Cancer stem cell therapy: Rhamnetin, an O-methylated flavonoid and anti-inflammatory agent, suppresses the expression of activator protein-1 member Fra-1 via up regulation of its target gene, 13/March/2014, 22.17
March 13, 2014
Treating human cancer with a Diabetic pill: Acarbose, an anti-diabetic drug used to treat non-insulin-dependent Diabetes Mellitus, suppresses the expression of c-Myc via up regulation of its target gene, 13/March/2014, 22.34
March 13, 2014
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, The TII-Diabetes drug Acarbose inhibits reprogramming of differentiated cells into induced pluripotent stem cells through its target genes, 13/March/2014, 22.28,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Comments are closed.